Free tool
FAERS Monitor: Cholbam
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205750 or its brand name (Cholbam, Cholic Acid). Reports on generic versions are filed under their own applications.
Reports
403
Serious
190
47% of reports
Hospitalization
89
Death reported
72
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea58
- death40
- vomiting29
- pyrexia21
- seizure20
- constipation19
- aspartate aminotransferase increased18
- alanine aminotransferase increased17
- disease progression16
- abdominal pain13
- cough13
- nasopharyngitis13
- decreased appetite11
- gastrooesophageal reflux disease10
- liver function test increased10
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2009 | 1 |
| 2015 | 3 |
| 2016 | 20 |
| 2017 | 18 |
| 2018 | 40 |
| 2019 | 43 |
| 2020 | 47 |
| 2021 | 39 |
| 2022 | 31 |
| 2023 | 115 |
| 2024 | 28 |
| 2025 | 9 |
| 2026 | 9 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,756 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| liver function test increasedSignal | 10 | 24.3 | 13.2 | 201 |
| aspartate aminotransferase increasedSignal | 18 | 17.7 | 11.3 | 268 |
| alanine aminotransferase increasedSignal | 17 | 14.5 | 9.1 | 200 |
| seizureSignal | 20 | 9.0 | 5.9 | 136 |
| disease progressionSignal | 16 | 7.1 | 4.4 | 78 |
| gastrooesophageal reflux diseaseSignal | 10 | 6.5 | 3.5 | 41 |
| diarrhoeaSignal | 58 | 4.7 | 3.7 | 170 |
| constipationSignal | 19 | 4.5 | 2.9 | 50 |
| nasopharyngitisSignal | 13 | 3.7 | 2.2 | 23 |
| vomitingSignal | 29 | 3.2 | 2.3 | 43 |
| pyrexiaSignal | 21 | 3.2 | 2.1 | 30 |
| abdominal painSignal | 13 | 2.9 | 1.7 | 15 |
| decreased appetiteSignal | 11 | 2.5 | 1.4 | 8 |
| deathSignal | 40 | 2.4 | 1.8 | 33 |
| coughSignal | 13 | 2.4 | 1.4 | 10 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.